Effects of teriparatide on fusion rates in patients undergoing complex foot and ankle arthrodesis
| Autor: | Bong Mo Koo, Se Hyun Yang, Jung Ho Park, Hee Seop Lee, Gi Won Choi, Hak Jun Kim, Hak Kyu Kim, Dong Hun Suh |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Adult
medicine.medical_specialty Arthrodesis medicine.medical_treatment Nonunion Avascular necrosis 03 medical and health sciences 0302 clinical medicine Risk Factors Teriparatide medicine Deformity Humans Orthopedics and Sports Medicine Aged Retrospective Studies 030222 orthopedics Bone Transplantation Bone Density Conservation Agents business.industry Osteonecrosis 030229 sport sciences Middle Aged medicine.disease Surgery medicine.anatomical_structure Treatment Outcome Female medicine.symptom Ankle business Complication Foot (unit) Ankle Joint medicine.drug |
| Zdroj: | Foot and ankle surgery : official journal of the European Society of Foot and Ankle Surgeons. 26(7) |
| ISSN: | 1460-9584 |
| Popis: | Background Here, we determined whether teriparatide treatment would increase fusion rates after foot and ankle arthrodesis by comparing treatment results between patients with high-risk factors for nonunion who received teriparatide against those who did not. Methods We retrospectively reviewed 66 consecutive patients who underwent foot and ankle arthrodesis. The inclusion criterion was the presence of at least one of the following risk factors for nonunion after previous foot and ankle arthrodesis: deformity, bone defects, avascular necrosis, and nonunion. Sixteen patients were finally enrolled and divided into 2 groups: 8 patients received teriparatide treatment after fusion surgery (PTH group), and 8 patients did not (control group). Results The fusion rate was significantly greater in the PTH group than in the control group (100% vs 50%). Four patients in the control group developed nonunion, 3 of whom underwent revision fusion; however, all patients received the teriparatide treatment after revision surgery and subsequently achieved union. No significant differences in demographics, fusion sites, and complication rates were found. Conclusion Though the sample size was small, the current study suggests that teriparatide administration may improve fusion rates in patients with high-risk factors for nonunion after foot and ankle arthrodesis. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect